Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
NEW YORK (Reuters Health) – The incidence of non-Hodgkin’s lymphoma (NHL) is increased somewhat in patients with diabetes, according to results of a meta-analysis published in Diabetes Care…
NEW YORK (Reuters Health) – The results of a case-control study suggest that the benefit of colonoscopy in preventing colorectal cancer deaths is largely limited to left-sided malignancies.…
NEW YORK (Reuters Health) – Results of a phase I trial suggest that intralesional transfer of plasmid interleukin (IL)-12 enhanced by electroporation for treatment of metastatic melanoma is…
NEW YORK (Reuters Health) – While prophylactic cranial irradiation can reduce the occurrence of brain metastases and improve survival in patients treated for extensive-disease small-cell lung cancer, it…
NEW YORK (Reuters Health) – In patients with resectable cancer of the pancreas, the use of neoadjuvant radiation therapy over surgery alone or surgery plus postoperative radiation therapy…
By Megan Rauscher NEW YORK (Reuters Health) – Among US Latinas, a greater degree of European genetic ancestry is associated with increased breast cancer risk, results of a…
NEW YORK (Reuters Health) – The results of a new study reaffirm the importance of treating heterozygous familial hypercholesterolemia (FH) with statins, linking therapy with reductions in all-cause,…
NEW YORK (Reuters Health) – A brief discussion among members of the operating room team just before surgery begins to outline the procedure and review important components can…
NEW YORK (Reuters Health) – The incidence of venous thromboembolism in patients with advanced cancer is increased by about 33% during treatment with the angiogenesis inhibitor bevacizumab, the…
NEW YORK (Reuters Health) – A history of migraine is strongly associated with reduced risk of hormone receptor-positive invasive breast cancer among postmenopausal women, according to findings from…
